TABLE 2.
Quality assessment of the experiments included in the studies.
| Study (year) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Liang et al. (1991) | + | - | + | NR | + | NR | - | + | NR | NR | 4 |
| Zhang et al. (2012) | + | - | + | NR | + | - | - | + | NR | NR | 4 |
| Fang et al. (2012) | + | + | + | NR | + | NR | - | + | NR | NR | 5 |
| Cui et al. (2018) | + | + | + | + | + | NR | - | + | NR | NR | 6 |
| Li et al. (2020) | + | + | - | + | + | NR | - | + | + | + | 7 |
| Sun et al. (2014) | + | + | + | + | + | + | - | + | + | + | 9 |
| Liu et al. (2019) | + | + | - | NR | + | + | - | + | + | NR | 6 |
| Ye et al. (2021) | + | + | - | + | + | NR | - | + | + | + | 7 |
| Wang et al. (2020b) | + | + | - | + | + | NR | - | + | + | + | 7 |
| Deng (2010) | + | NR | - | NR | + | - | - | - | NR | NR | 2 |
| Xia et al. (2021) | + | + | + | + | + | NR | - | + | + | NR | 7 |
| Wang (2013) | + | NR | + | NR | + | + | - | + | NR | NR | 5 |
| Peng et al. (2020) | + | + | + | NR | + | + | - | + | + | + | 8 |
1: peer-reviewed publication; 2: statements describing control of temperature; 3: randomization to treatment group; 4: allocation concealment; 5: blinded assessment of outcome; 6: use of anesthetic had no apparent intrinsic myocardial preservation or neuroprotective effect; 7: use of animals with relevant comorbidities; 8: sample size calculation; 9: compliance with animal welfare regulations; 10: declared any potential conflict of interest; NR, not reported.